HealthWorld WHO authorises second vaccine against dengue amid outbreaks in the Americas by Barbados Today 16/05/2024 written by Barbados Today Updated by Brittany Brewster 16/05/2024 2 min read A+A- Reset FacebookTwitterLinkedinWhatsappEmail 996 The World Health Organization on Wednesday authorised a second dengue vaccine, a move that could provide protection for millions worldwide against the mosquito-borne disease that has already sparked numerous outbreaks across the Americas this year. In a statement on Wednesday, the UN health agency said it approved the dengue vaccine made by the Japanese pharmaceutical Takeda, recommending its use in children between six to 16 years old living in regions with high rates of dengue. The two-dose vaccine protects against the four types of dengue. Takedaโs dengue vaccine, known as Qdenga, was previously given the nod by theย European Medicines Agencyย in 2022. WHOโs approval now means that donors and other UN agencies can purchase the vaccine for poorer countries. Studies have shown Takedaโs vaccine is about 84% effective in preventing people from being hospitalised with dengue and about 61% effective in stopping symptoms. WHOโs Rogerio Gaspar, director for the agencyโs approvals of medicines and vaccines, said it was โan important step in the expansion of global access to dengue vaccines.โ He noted it was the second immunisation the UN agency had authorised for dengue. You Might Be Interested In Immunisation Record Inspections To Start Monday Ministry of Health – No cases of H1N1 virus so far this year Fogging schedule for January 22 โ 25 The first vaccine WHO approved was made byย Sanofi Pasteur, which was later found to increase the risk of severe dengue in people who had not previously been infected with the disease. There is no specific treatment forย dengue, a leading cause of serious illness and death in roughly 120 Latin American and Asian countries. While about 80% of infections are mild, severe cases of dengue can lead to internal bleeding, organ failure and death. Last week WHO reported there were 6.7 million suspected cases of dengue in theย Americas, an increase of 206% compared with the same period in 2023. In March, authorities inย Rio de Janeiroย declared a public health emergency over its dengue epidemic and the country began rolling out the Takeda vaccine, aiming to inoculate at least three million people. Last year WHO said cases of dengue haveย spiked tenfoldย over the last generation, withย climate changeย and the increasing range of the mosquitoes that carry dengue partly to blame for the diseaseโs spread. SOURCE: AP Barbados Today Stay informed and engaged with our digital news platform. The leading online multimedia news resource in Barbados for news you can trust. You may also like Two women, two cancer journeys, one message: screen early 14/10/2026 Early treatment takes centre stage in MS care forum 12/10/2026 Rise in MS diagnosis drives call for early care 11/10/2026